Ashfield Capital Partners, LLC Novartis Ag Transaction History
Ashfield Capital Partners, LLC
- $1.19 Billion
- Q3 2022
A detailed history of Ashfield Capital Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 4,727 shares of NVS stock, worth $547,197. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,727
Previous 4,727
-0.0%
Holding current value
$547,197
Previous $400,000
10.25%
% of portfolio
0.03%
Previous 0.03%
Shares
18 transactions
Others Institutions Holding NVS
# of Institutions
1,524Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.37 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.2 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$996 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$817 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$783 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...